-
1 Comment
Caplin Point Laboratories Limited is currently in a long term uptrend where the price is trading 29.7% above its 200 day moving average.
From a valuation standpoint, the stock is 26.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
Caplin Point Laboratories Limited's total revenue rose by 20.2% to $3B since the same quarter in the previous year.
Its net income has increased by 10.1% to $645M since the same quarter in the previous year.
Finally, its free cash flow grew by 286.9% to $2B since the same quarter in the previous year.
Based on the above factors, Caplin Point Laboratories Limited gets an overall score of 5/5.
| Exchange | NSE |
|---|---|
| CurrencyCode | INR |
| ISIN | INE475E01026 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 28.01 |
|---|---|
| Target Price | 2472 |
| Dividend Yield | 0.3% |
| Beta | 0.35 |
| Market Cap | 144B |
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CAPLIPOINT.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
